Galectin Therapeutics (GALT) Preferred Shares (2010 - 2026)
Galectin Therapeutics (GALT) posted Preferred Shares of $480,000 for Q2 2026, down 2.0% from $490,000 a year earlier and unchanged from the prior quarter.
Powered by 
Analysis
Galectin Therapeutics (GALT) Preferred Shares (2010 - 2026) Analysis & Trends
At the end of FY2025, Galectin Therapeutics' Preferred Shares came in at $490,000, down 2.0% from FY2024.
- Annual Preferred Shares shows a five-year compound annual growth rate of -1.4% (FY2020 to FY2025).
- In prior years, Galectin Therapeutics' Preferred Shares was $500,000 in FY2024 (unchanged), $500,000 in FY2023 (-2.0%), $510,000 in FY2022 (-3.2%) and $527,000 in FY2021 (unchanged).
- Quarterly Preferred Shares has run from a low of $480,000 in Q1 2026 to a high of $527,000 in Q1 2022 over five years.
- On a year-over-year basis, Preferred Shares has declined in each of the last five quarters, with an average decline of 1.8% over the last eight quarters.
- Over the past five years, the year-over-year decline in Preferred Shares ranged from 0.0% (Q1 2025) to 4.0% (Q1 2026).
- According to Business Quant data, Preferred Shares for the three prior quarters was $480,000 (Q1 2026), $490,000 (Q4 2025) and $490,000 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Preferred Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | - |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | - |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | - |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | - |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | - |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | - |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | - |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | - |
| 10 | Galectin Therapeutics | 224.13 Mn | 167.48 Mn | - | 480,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 480,000.00 |
| Mar 31, 2026 | 480,000.00 |
| Dec 31, 2025 | 490,000.00 |
| Sep 30, 2025 | 490,000.00 |
| Jun 30, 2025 | 490,000.00 |
| Mar 31, 2025 | 500,000.00 |
| Dec 31, 2024 | 500,000.00 |
| Sep 30, 2024 | 500,000.00 |
| Jun 30, 2024 | 500,000.00 |
| Mar 31, 2024 | 500,000.00 |
| Dec 31, 2023 | 500,000.00 |
| Sep 30, 2023 | 510,000.00 |
| Jun 30, 2023 | 510,000.00 |
| Mar 31, 2023 | 510,000.00 |
| Dec 31, 2022 | 510,000.00 |
| Sep 30, 2022 | 510,000.00 |
| Jun 30, 2022 | 510,000.00 |
| Mar 31, 2022 | 527,000.00 |
| Dec 31, 2021 | 527,000.00 |
| Sep 30, 2021 | 527,000.00 |
API Access
Galectin Therapeutics Preferred Shares API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=preferred-shares&ticker=GALT&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "preferred-shares", "ticker": "GALT", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=preferred-shares&ticker=GALT&period=max&api_key=YOUR_API_KEY");
const data = await res.json();